Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 12, 2008, Pages 4840-4845

  De Castro, Whocely Victor ^a   Mertens Talcott, Susanne ^a   Derendorf, Hartmut ^a   Butterweck, Veronika ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Flavonoids; Furanocoumarins; Grapefruit; Intestinal transport; Juice; P glycoprotein; Rats; Talinolol

Indexed keywords

AURANTIIN; BERGAMOTTIN; FLAVANONE DERIVATIVE; GLYCOPROTEIN P; NARINGENIN; PROPANOLAMINE DERIVATIVE; PSORALEN DERIVATIVE; TALINOLOL;

ANIMAL; ARTICLE; BEVERAGE; BLOOD; CHEMISTRY; DRUG EFFECT; FRUIT; GRAPEFRUIT; INTESTINE; MALE; METABOLISM; RAT; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BEVERAGES; BIOLOGICAL TRANSPORT; CITRUS PARADISI; FLAVANONES; FRUIT; INTESTINES; MALE; P-GLYCOPROTEIN; PROPANOLAMINES; PSORALENS; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY;

CITRUS X PARADISI; RATTUS;

EID: 47349108866     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf0728451     Document Type: Article

References (51)

1. Lown, K. S.; Bailey, D. G.; Fontana, R. J.; Janardan, S. K.; Adair, C. H.; Fortlage, L. A.; Brown, M. B.; Guo, W.; Watkins, P. B. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J. Clin. Invest. 1997, 99 (10), 2545-53.
2. Uno, T.; Ohkubo, T.; Sugawara, K.; Higashiyama, A.; Motomura, S.; Ishizaki, T. Effects of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site. Eur. J. Clin. Pharmacol. 2000, 56 (9-10), 643-9.
3. Takanaga, H.; Ohnishi, A.; Murakami, H.; Matsuo, H.; Higuchi, S.; Urae, A.; Irie, S.; Furuie, H.; Matsukuma, K.; Kimura, M.; Kawano, K.; Orii, Y.; Tanaka, T.; Sawada, Y. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clin. Pharmacol. Ther. 2000, 67 (3), 201-14.
4. Kantola, T.; Kivisto, K. T.; Neuronen, P. J. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin. Pharmacol. Ther. 1998, 63 (4), 397-402.
5. Lilja, J. J.; Neuvonen, M.; Neuvonen, P. J. Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin. Br. J. Clin. Pharmacol. 2004, 58 (1), 56-60.
6. Goho, C. Oral midazolam-grapefruit juice drug interaction. Pediatr. Dent. 2001, 23 (4), 365-6.
7. Ozdemir, M.; Aktan, Y.; Boydag, B. S.; Cingi, M. I.; Musmul, A. Interaction between grapefruit juice and diazepam in humans. Eur. J. Drug Metab. Pharmacokinet. 1998, 23 (1), 55-9.
8. Tian, R.; Koyabu, N.; Takanaga, H.; Matsuo, H.; Ohtani, H.; Sawada, Y. Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm. Res. 2002, 19 (6), 802-9.
9. Honda, Y.; Ushigome, F.; Koyabu, N.; Morimoto, S.; Shoyama, Y.; Uchiumi, T.; Kuwano, M.; Ohtani, H.; Sawada, Y. Effects of grapefruit juice and orange juice components on P-glycoprotein-and MRP2-mediated drug efflux. Br. J. Pharmacol. 2004, 143 (7), 856-64.
10. Dresser, G. K.; Kim, R. B.; Bailey, D. G. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. Clin. Pharmacol. Ther. 2005, 77 (3), 170-7.
11. Kamath, A. V.; Yao, M.; Zhang, Y.; Chong, S. Effect of fruit juices on the oral bioavailability of fexofenadine in rats. J. Pharm. Sci. 2005, 94 (2), 233-9.
12. Kunta, J. R.; Sinko, P. J. Intestinal drug transporters: in vivo function and clinical importance. Curr. Drug Metab. 2004, 5 (1), 109-24.
13. Peng, S. X.; Ritchie, D. M.; Cousineau, M.; Danser, E.; Dewire, R.; Floden, J. Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A. J. Pharm. Sci. 2006, 95 (9), 1984-93.
14. Kim, R. B. Organic anion-transporting polypeptide (OATP) transporter family and drug disposition. Eur. J. Clin. Invest. 2003, 33 (s2), 1-5.
15. Terada, T.; Inui, K. Peptide transporters: structure, function, regulation and application for drug delivery. Curr. Drug Metab. 2004, 5, 85-94.
16. Tirona, R.G.; Kim, R. B. Pharmacogenomics of organic anion-transporting polypeptides (OATP). Adv. Drug Delivery Rev. 2002, 54, 1343-1352.
17. Glaeser, H.; Bailey, D. G.; Dresser, G. K.; Gregor, J. C.; Schwarz, U. I.; McGrath, J. S.; Jolicoeur, E.; Lee, W.; Leake, B. F.; Tirona, R. G.; Kim, R. B. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin. Pharmacol. Ther. 2007, 81 (3), 362-70.
18. Bailey, D. G.; Dresser, G. K. Interactions between grapefruit juice and cardiovascular drugs. Am. J. Cardiovasc. Drugs 2004, 4 (5), 281-97.
19. Takanaga, H.; Ohnishi, A.; Matsuo, H.; Sawada, Y. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. Biol. Pharm. Bull. 1998, 21 (10), 1062-6.
20. Eagling, V. A.; Profit, L.; Back, D. J. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of me HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br. J. Clin. Pharmacol. 1999, 48 (4), 543-52.
21. Wang, E. J.; Casciano, C. N.; Clement, R. P.; Johnson, W. W. Inhibition of P-glycoprotein transport function by grapefruit juice psoralen. Pharm. Res. 2001, 18 (4), 432-8.
22. de Castro, W. V.; Mertens-Talcott, S.; Derendorf, H.; Butterweck, V. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells. J. Pharm. Sci. 2007, 96 (10), 2808-17.
23. Mertens-Talcott, S. U.; De Castro, W. V.; Manthey, J. A.; Derendorf, H.; Butterweck, V. Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells. J. Agric. Food Chem. 2007, 55 (7), 2563-8.
24. Satoh, H.; Yamashita, F.; Tsujimoto, M.; Murakami, H.; Koyabu, N.; Ohtani, H.; Sawada, Y. Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab. Dispos. 2005, 33 (4), 518-23.
25. Bailey, D. G.; Dresser, G. K.; Kreeft, J. H.; Munoz, C.; Freeman, D. J.; Bend, J. R. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin. Pharmacol. Ther. 2000, 68 (5), 468-77.
26. Tassaneeyakul, W.; Guo, L. Q.; Fukuda, K.; Ohta, T.; Yamazoe, Y. Inhibition selectivity of grapefruit juice components on human cytochromes P450. Arch. Biochem. Biophys. 2000, 378 (2), 356-63.
27. Oertel, R.; Richter, K. The metabolism of the beta receptor blocker talinolol in humans - relationship between structure, polarity and amount excreted. Pharmazie 1995, 50 (9), 637-8.
28. Ameer, B.; Weintraub, R. A. Drug interactions with grapefruit juice. Clin. Pharmacokinet. 1997, 33 (2), 103-121.
29. Spahn-Langgudi, H.; Langguth, P. Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur. J. Pharm. Sci. 2001, 12 (4), 361-7.
30. Shelton, M. J.; Wynn, H. E.; Hewitt, R. G.; DiFrancesco, R. Effects of grapefruit juice on pharmacokinetic exposure to indinavir in HIV-positive subjects. J. Clin. Pharmacol. 2001, 41 (4), 435-42.
31. Schwarz, U. I.; Seemann, D.; Oertel, R.; Miehlke, S.; Kublish, E.; Fromm, M. F.; Kim, R. B.; Bailey, D. G.; Kirch, W. Grapefruit juice ingestion significantly reduces talinolol bioavailability. Clin. Pharmacol. Ther. 2005, 77, 291-301.
32. De Castro, W. V.; Mertens-Talcott, S.; Rubner, A.; Butterweck, V.; Derendorf, H. Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies. J. Agric. Food Chem. 2006, 54 (1), 249-55.
33. Lilja, J. J.; Kivisto, K. T.; Neuvonen, P. J. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin. Pharmacol. Ther. 1998, 64 (5), 477-83.
34. Lilja, J. J.; Kivisto, K. T.; Neuvonen, P. J. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clin. Pharmacol. Ther. 1999, 66 (2), 118-27.
35. Lilja, J. J.; Kivisto, K. T.; Neuvonen, P. J. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Clin. Pharmacol. Ther. 2000, 68 (4), 384-90.
36. Zeller, W.; Weber, H.; Panoussis, B.; Bürge, T.; Bergmann, R. Refinement of blood sampling from the sublingual vein of rats. Lab. Anim. 1998, 32, 369-376.
37. Goosen, T. C.; Cillie, D.; Bailey, D. G.; Yu, C.; He, K.; Hollenberg, P. F.; Woster, P. M.; Cohen, L.; Williams, J. A.; Rheeders, M.; Dijkstra, H. P. Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans. Clin. Pharmacol. Ther. 2004, 76 (6), 607-17.
38. Cvetkovic, M.; Leake, B.; Fromm, M. F.; Wilkinson, G. R.; Kim, R. B. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab. Dispos. 1999, 27 (8), 866-71.
39. Dresser, G. K.; Bailey, D. G.; Leake, B. F.; Schwarz, U. I.; Dawson, P. A.; Freeman, D. J.; Kim, R. B. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther. 2002, 71 (1), 11-20.
40. Spahn-Langguth, H.; Baktir, G.; Radschuweit, A.; Okyar, A.; Terhaag, B.; Ader, P.; Hanafy, A.; Langgudi, P. P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound. Int. J. Clin. Pharmacol. Ther. 1998, 36 (1), 16-24.
41. Schwarz, U. I.; Gramatte, T.; Krappweis, J.; Berndt, A.; Oertel, R.; von Richter, O.; Kirch, W. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans. Clin. Pharmacol. Ther. 1999, 65 (3), 283-90.
42. Glaeser, H.; Drescher, S.; Eichelbaum, M.; Fromm, M. F. Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes. Br. J. Clin. Pharmacol. 2005, 59 (2), 199-206.
43. Brage, R.; Cortijo, J.; Esplugues, J.; Esplugues, J. V.; Marti-Bonmati, E.; Rodriguez, C. Effects of calcium channel blockers on gastric emptying and acid secretion of the rat in vivo. Br. J. Pharmacol. 1986, 89 (4), 627-33.
44. Ameer, B.; Weintraub, R. A.; Johnson, J. V.; Yost, R. A.; Rouseff, R. L. Flavanone absorption after naringin, hesperidin, and citrus administration. Clin. Pharmacol. Ther. 1996, 60 (1), 34-40.
45. Dresser, M. J.; Gray, A. T.; Giacomini, K. M. Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1). J. Pharmacol. Exp. Ther. 2000, 292 (3), 1146-52.
46. Drewe, J.; Ball, H. A.; Beglinger, C.; Peng, B.; Kemmler, A.; Schachinger, H.; Haefeli, W. E. Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine. Br. J. Clin. Pharmacol. 2000, 50 (3), 237-46.
47. Thompson, S. J.; Koszdin, K.; Bernards, C. M. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology 2000, 92 (5), 1392-9.
48. Rouseff, R. L. Liquid chromatographic determination of naringin and neohesperidin as a detector of grapefruit juice in orange juice. J. Assoc. Off. Anal. Chem. 1988, 71 (4), 798-802.
49. Robards, K.; Li, X.; Antolovich, M.; Boyd, S. Characterization of citrus by chromatographic analysis of flavonoids. J. Sci. Food Agric. 1997, 75, 87-101.
50. Fukuda, K.; Guo, L.; Ohashi, N.; Yoshikawa, M.; Yamazoe, Y. Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction. J. Chromatogr., B: Biomed. Sci. Appl. 2000, 741 (2), 195-203.
51. Ho, P. C.; Saville, D. J.; Coville, P. F.; Wanwimolruk, S. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products. Pharm. Acta Helv. 2000, 74 (4), 379-85.